- Home
- CLPR vs MDAI Comparison
CLPR vs MDAI Comparison
Compare CLPR & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLPR | MDAI |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.4M | 51.5M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CLPR | MDAI |
|---|---|---|
| Price | $3.30 | $1.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 58.4K | ★ 105.4K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | ★ 10.73% | N/A |
| EPS Growth | N/A | ★ 65.88 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,997,000.00 | $19,650,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.82 | N/A |
| 52 Week Low | $2.69 | $1.18 |
| 52 Week High | $4.34 | $2.97 |
Technical Indicators
Market Signals| Indicator | CLPR | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 57.33 | 47.65 |
| Support Level | $3.28 | $1.50 |
| Resistance Level | $3.54 | $1.67 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 45.93 | 38.46 |
Price Performance
Historical ComparisonAbout CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.